## Abstract The effect of conformational restriction of the C9βN10 bridge on inhibitory potency and selectivity of trimetrexate against dihydrofolate reductase, was studied. Specifically three nonclassical tricyclic 1,3βdiaminoβ8β(3β²,4β²,5β²βtrimethoxybenzyl)β7,9βdihydroβpyrrolo[3,4β__c__]pyrido[2,3β
Pyrrolo[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines as conformationally restricted analogues of the antibacterial agent trimethoprim
β Scribed by Lee F Kuyper; Janice M Garvey; David P Baccanari; John N Champness; David K Stammers; Christopher R Beddell
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 876 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0968-0896
No coin nor oath required. For personal study only.
β¦ Synopsis
Conformationally restricted analogues of the antibacterial agent trimethoprim (TMP) were designed to mimic the conformation of drug observed in its complex with bacterial dihydrofolate reductase (DHFR). This conformation of TMP was achieved by linking the 4-amino function to the methylene group by one- and two-carbon bridges. A pyrrolo[2,3-d]pyrimidine, a dihydro analogue, and a tetrahydropyrido[2,3-d]pyrimidine were synthesized and tested as inhibitors of DHFR. One analogue showed activity equivalent to that of TMP against DHFR from three species of bacteria. An X-ray crystal structure of this inhibitor bound to Escherichia coli DHFR was determined to evaluate the structural consequences of the conformational restriction.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v